Inventor
WAGNER EUGENE R
24 patents
⚠️ This page may combine multiple inventors who share the name “WAGNER EUGENE R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DOW CHEMICAL CO
19 patentsUS4078084AMar 7, 1978
Novel hypolipidemic 2-(3,5-di-tert-butyl-4-hydroxyphenyl)thio carboxamides
DOW CHEMICAL CO53 citations94
US4076841AFeb 28, 1978
Hypolipidemic 2-(3,5-di-tert-butyl-4-hydroxyphenyl)thio carboxamides
DOW CHEMICAL CO65 citations94
US4029812AJun 14, 1977
Novel hypolipidemic 2-(3,5-di-tert-butyl-4-hydroxyphenyl)thio carboxamides
DOW CHEMICAL CO72 citations94
US4067998AJan 10, 1978
2-((3,5-Di-tert-butylphenyl)thio) alkanoic acids and derivatives
DOW CHEMICAL CO8 citations73
US4012523AMar 15, 1977
Hypolipidemic 2-(3,5-di-tert-butyl-4-hydroxyphenyl)-(thio or sulfonyl) alkanoic acids and derivatives
DOW CHEMICAL CO8 citations73
US4143151AMar 6, 1979
Method for treating hyperglycemia in mammals using arylamino benzoic acids
DOW CHEMICAL CO8 citations70
US4105791AAug 8, 1978
Hypolipidemic cycloalkylaminobenzoic acids
DOW CHEMICAL CO2 citations63
US4218475AAug 19, 1980
Hypolipidemic benzylaminobenzene alkanoic or alkenoic acids
DOW CHEMICAL CO4 citations60
US4062975ADec 13, 1977
Amino substituted arylthio-alkanoic acids having hypolipidemic activity
DOW CHEMICAL CO2 citations60
US4133890AJan 9, 1979
Hypolipidemic compositions and method employing derivatives of 4-(((1,3-benzodioxol-5-yl)methyl)amino)benzoic acid
DOW CHEMICAL CO2 citations59
US4286090AAug 25, 1981
Novel tetrazolo [4,5-C][1,2,3]benzotriazines
DOW CHEMICAL CO1 citations52
US4192884AMar 11, 1980
Substituted 4-(((thienyl)methyl)-amino)benzoic acids and a method for treating hypolipidemia
DOW CHEMICAL CO1 citations52
US4263320AApr 21, 1981
Hypoglycemic phenylpropynylamino benzoic acids
DOW CHEMICAL CO0 citations49
US4103029AJul 25, 1978
Amino substituted arylthio-alkanoic acids having hypolipidemic activity
DOW CHEMICAL CO0 citations49
US4103027AJul 25, 1978
Amino substituted arylthio-alkanoic acids having hypolipidemic activity
DOW CHEMICAL CO0 citations49
US4207330AJun 10, 1980
Method for treating hyperglycemia in mammals using arylamino benzoic acids
DOW CHEMICAL CO1 citations48
US4206223AJun 3, 1980
Method for treating hyperglycemia in mammals using 4-(((1,3-benzodioxol-5-yl)methyl)amino)benzoic acid or derivatives thereof
DOW CHEMICAL CO0 citations48
US4181737AJan 1, 1980
4-((3-Methoxyphenyl)amino)benzoic acid, a method for treating hyperlipidemia, and compositions thereof
DOW CHEMICAL CO1 citations48
US4178385ADec 11, 1979
Method for treating hyperlipidemia in primates using 4-((4-fluorophenylmethyl)amino)benzoic acid
DOW CHEMICAL CO0 citations48
MERRELL DOW PHARMA
4 patentsUS4584379AApr 22, 1986
Isoquinoline thromboxane synthetase inhibitors
MERRELL DOW PHARMA36 citations92
US4857663AAug 15, 1989
Hypoglycemic N-(2-substituted-3-dialkylamino-2-propenylidene)-N-alkylalkanaminium salts
MERRELL DOW PHARMA3 citations62
US4788335ANov 29, 1988
Hypoglycemic N-(2-substituted-3-dialkylamino-2-propenylidene)-N-alkylalkanaminium salts
MERRELL DOW PHARMA4 citations62
US4533677AAug 6, 1985
Hypoglycemic N-(2-substituted-3-Dialkylamino-2-propenylidene)-N-alkylalkanaminium salts
MERRELL DOW PHARMA1 citations51